ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
BMC Medical Imaging
◽
10.1186/s12880-016-0158-4
◽
2016
◽
Vol 16
(1)
◽
Cited By ~ 9
Author(s):
Sheena L. Dupuy
◽
Fariha Khalid
◽
Brian C. Healy
◽
Sonya Bakshi
◽
Mohit Neema
◽
...
Keyword(s):
Multiple Sclerosis
◽
Spinal Cord
◽
Interferon Beta
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
◽
Spinal Cord Volume
Download Full-text
Related Documents
Cited By
References
The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis
Journal of Neuroimaging
◽
10.1111/jon.12378
◽
2016
◽
Vol 27
(1)
◽
pp. 33-36
◽
Cited By ~ 12
Author(s):
Tarun Singhal
◽
Shahamat Tauhid
◽
Shelley Hurwitz
◽
Mohit Neema
◽
Rohit Bakshi
Keyword(s):
Multiple Sclerosis
◽
Spinal Cord
◽
Glatiramer Acetate
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
◽
Spinal Cord Volume
Download Full-text
Interferon beta-1b therapy in relapsing-remitting multiple sclerosis: Study design and preliminary results
Electroencephalography and Clinical Neurophysiology
◽
10.1016/s0013-4694(97)88414-7
◽
1997
◽
Vol 103
(1)
◽
pp. 99
Author(s):
G Salemi
Keyword(s):
Multiple Sclerosis
◽
Study Design
◽
Interferon Beta
◽
Preliminary Results
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
The course of cervical spinal cord atrophy rate and its relationship with NEDA in relapsing remitting multiple sclerosis
Acta Neurologica Belgica
◽
10.1007/s13760-021-01595-4
◽
2021
◽
Author(s):
Vedat Cilingir
◽
Hüseyin Akdeniz
Keyword(s):
Multiple Sclerosis
◽
Spinal Cord
◽
Cervical Spinal Cord
◽
Spinal Cord Atrophy
◽
Atrophy Rate
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
Clinical Neurology and Neurosurgery
◽
10.1016/j.clineuro.2013.09.024
◽
2013
◽
Vol 115
◽
pp. S65-S69
◽
Cited By ~ 13
Author(s):
Jelena Drulovic
◽
Jelena Kostic
◽
Sarlota Mesaros
◽
Irena Dujmovic Basuroski
◽
Nebojsa Stojsavljevic
◽
...
Keyword(s):
Multiple Sclerosis
◽
Interferon Beta
◽
Disability Progression
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
PNR1: COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF INTERFERON BETA-IB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN POLAND (2-YEARS PERSPECTIVE)
Value in Health
◽
10.1016/s1098-3015(11)70789-6
◽
2000
◽
Vol 3
(5)
◽
pp. 362-363
Author(s):
E Orlewska
◽
P Mierzejewski
◽
A Czlonkowska
Keyword(s):
Multiple Sclerosis
◽
Cost Effectiveness
◽
Interferon Beta
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis
JAMA Neurology
◽
10.1001/jamaneurol.2013.1017
◽
2013
◽
Vol 70
(2)
◽
pp. 248
◽
Cited By ~ 10
Author(s):
Benjamin M. Greenberg
◽
Laura Balcer
◽
Peter A. Calabresi
◽
Bruce Cree
◽
Anne Cross
◽
...
Keyword(s):
Multiple Sclerosis
◽
Interferon Beta
◽
Disability Prevention
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
5-31-07 Interferon beta 1a in the treatment of relapsing/remitting multiple sclerosis
Journal of the Neurological Sciences
◽
10.1016/s0022-510x(97)86469-6
◽
1997
◽
Vol 150
◽
pp. S321
Author(s):
R. Ljapcev
◽
L. Gogovska
◽
M. Tanovska
Keyword(s):
Multiple Sclerosis
◽
Interferon Beta
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of Bravo
Value in Health
◽
10.1016/j.jval.2012.03.803
◽
2012
◽
Vol 15
(4)
◽
pp. A149
Author(s):
C.A. Carroll
◽
M.A. Oleen-Burkey
Keyword(s):
United States
◽
Multiple Sclerosis
◽
Interferon Beta
◽
The United States
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Multiple Sclerosis Patients
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
How does alemtuzumab compare with interferon beta 1a in people with relapsing-remitting multiple sclerosis?
Cochrane Clinical Answers
◽
10.1002/cca.1996
◽
2018
◽
Author(s):
Jane Burch
◽
Loredana La Mantia
Keyword(s):
Multiple Sclerosis
◽
Interferon Beta
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States
Value in Health
◽
10.1016/j.jval.2018.04.1400
◽
2018
◽
Vol 21
◽
pp. S206
Author(s):
D Rao
◽
E Heidari
◽
KM Kamal
◽
AA Dashputre
Keyword(s):
United States
◽
Multiple Sclerosis
◽
Cost Effectiveness
◽
Interferon Beta
◽
The United States
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close